CD200 and rheumatoid arthritis: Indeed, the use of infliximab and methotrexate in rheumatoid arthritis patients resulted in up regulation of both peripheral CD200 and CD200R, a change that correlated to the clinical improvement of the disease as evidenced by reduced disease severity scores.